Discontinuation report MYLAN-PREGABALIN
Report ID | 51582 |
Drug Identification Number | 02382245 |
Brand name | MYLAN-PREGABALIN |
Common or Proper name | PREGABALIN |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | PREGABALIN |
Strength(s) | 150MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 60 BT |
ATC code | N03AX |
ATC description | ANTIEPILEPTICS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2018-07-03 |
Actual discontinuation date | 2018-07-03 |
Remaining supply date | 2018-07-03 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | Discontinued in shortage ID 51578. Last lot 3049241-1 Expires 30-Nov-18 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2018-06-05 | English | Compare |
v2 | 2018-06-05 | French | Compare |
v3 | 2018-07-03 | English | Compare |
v4 | 2018-07-03 | French | Compare |
v5 | 2018-08-01 | English | Compare |
v6 | 2018-08-01 | French | Compare |
Showing 1 to 6 of 6